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Abstract
Background: Talcosis, a granulomatous inflammation of the lungs caused by inhalation of talcum dust, is a rare
form of pneumoconiosis. Besides inhalative occupational exposure, intravenous abuse of adulterated drugs is a
major cause for this condition. Minerals such as talcum (magnesium silicate) and sand (predominant silicon
dioxide) are used to increase both volume and weight of illicit substances. In intravenous heroin-abuse, talcosis is a
well-known complication. Here we describe a case of talcosis caused by inhalative abuse of adulterated marijuana.
Clinical history: A 29-year old man presented with persistent fever, dyspnea and cervical emphysema. He
admitted consumption of ‘cut’ marijuana for several years, preferentially by water pipe smoking.
Morphologic findings: Lung-biopsies showed chronic interstitial lung disease, anthracotic pigments and
birefringent material. Energy dispersive x-ray spectroscopy revealed silicon-containing particles (1-2 μm) and fine
aluminum particles (< 1 μm), magnesium and several other elements forming a spectrum compatible with the
stated water pipe smoking of talcum-adulterated marijuana.
Conclusions: The exacerbated chronic interstitial lung disease in a 29-year old patient could be attributed to his
prolonged abuse of talcum-adulterated marjuana by histopathology and x-ray spectroscopy. Since cannabis
consumption is widely spread among young adults, it seems to be justified to raise attention to this form of
interstitial pulmonary disease.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnomx.eu/vs/krause/html/start.
html.
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Background
Pneumoconioses are restrictive pulmonary diseases
caused by chronic inhalation of mineral dust. In many
industrialised countries, improvements in occupational
health lead to a general decrease of pneumoconiosis
over the last 5 decades. Contrary to this trend, the inci-
dence of asbestosis strongly increased until a few years
ago rendering it the currently most frequently recorded
pneumoconiosis [1]. While talc (hydrated magnesium
silicate) is commonly used in various industrial pro-
cesses, its clinical relevance (Talcosis, ICD-10 J23.0) is
fairly low. In addition to chronic inhalation, intravenous
drug abuse is a major source of talc-related lung dis-
eases: As talc is used as filling material in tablets, intra-
venous abuse of drugs intended for oral application
causes deposition of the mineral in various organs, nota-
bly the lungs [2]. Illicit substances such as heroin are
often adulterated to increase volume and weight for
which talc is frequently used [3].
Talc deposition in the lungs typically causes granulo-
matous inflammation characterized by formation of for-
eign body granulomas of varying degree within a fibrotic
stroma. These granulomas are typically composed of
free or intracellular birefringent deposits accompanied
by multinucleated giant cells. They may also appear ill
defined with only few surrounding histiocytes.
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develop intra- and perivascular as well as in the
interstitium.
Radiologic findings include micronodular patterns of
diffuse or well defined nodules which may fuse with
progression to form larger opacities in the perihilar
regions. Other manifestations include interstitial thick-
ening and lower-lobe emphysema. High-resolution com-
puted tomography may show small centrilobular
nodules or ground-glass opacities presumably represent-
ing microscopic granulomas below tomography resolu-
tion. With progression of the disease heterogeneous
masses with internal foci of high attenuation resembling
talc deposition may develop [4].
Reports on adulteration of cannabis are rare and just
one publication describes the consequences of inhalative
abuse of cannabis adultered with mineralic substances
[5]. Here we present the case of a 29-year-old patient
who developed chronic interstitial pulmonary disease
most likely due to long-term smoking of marijuana
adulterated with mineral substances. The histological
d i a g n o s i sw a sc o n f i r m e db ye n e r g yd i s p e r s i v ex - r a y
spectroscopy which yielded a spectrum of elements
compatible with talcum as the leading contaminant.
Case presentation
Initial clinical presentation
The 29-year old patient was admitted to hospital treat-
ment with persistent fever (40°C), dyspnea with wet
cough and cervical emphysema. The symptoms had been
present for six days. Oral antibiosis (ciprofloxacin 2 ×
500 mg/d) had been prescribed prior to admission. The
histological findings following transbronchial biopsies led
to the initial conclusion of the interstitial pulmonary dis-
ease being caused by intravenous abuse either of adulter-
ated illicit substances or of dissolved tablets. Taken the
fact into account of locally available cannabis being com-
monly adulterated with substances such as sand and tal-
cum we reevaluated the lung biopsies and performed
energy dispersive x-ray spectroscopy (EDX).
History and clinical examination
Examination of the patient revealed no further patholo-
gic findings. In particular, auscultation of the lung and
heart was within normal limits and percussion indicated
regular lung margins. The patient admitted regular con-
sumption of cannabis by water-pipe smoking for several
years but denied abuse of any other drugs. There were
no signs of continued intravenous drug abuse nor evi-
dence of any occupational exposure.
Imaging
Chest x-rays revealed ubiquitous, centrally pronounced
infiltrates [Figure 1]. High-resolution computed
tomography scans confirmed the cervical emphysema
which extended into the mediastinum. Given the
absence of bullae and other specific radiologic findings,
the emphysema was considered as caused by the persis-
tent coughing. Furthermore, the scans showed bilateral
peribronchovascular alveolar shadows with groundglass-
appearance.
Clinical investigations
Upon admission blood tests showed high c-reactive pro-
tein (145 mg/L) and moderate leukocytosis (15000/μL).
Arterial blood gas analysis indicated partial respiratory
insufficiency (pO2 57.3 mmHg, pCO2 35.5 mmHg, pH
7.465). Spirometric studies were suggestive of restrictive
lung disease (VC 3.73 L = 73%, FEV1 2.94 L = 71%, FEV1/
VCmax 79, RAWtot 46%, TLC 4.98 L = 74%, RV 1.25 L =
76%). Bronchoalveolar lavage revealed slightly increased
absolute cell numbers of 16/μL with relative increase of
neutrophils (13%) as well as macrophages containing large
amounts of anthracotic pigments compatible with heavy
smoking. Aerobic and anaerobic cultures yielded no
pathologic growth. Negative polymerase chain reaction for
mycobacterium tuberculosis was subsequently confirmed
by negative cultures. Immunological screening for var-
ious specific IgG-antibodies was negative (i. e. pigeon,
budgerigar, aspergillus fumigates and versicolor) rendering
an extrinsic allergic alveolitis unlikely. A urine quick-test
for legionella antigens was negative. The patient was tested
negative for HIV and hepatitis C. Immunofluorescence
microscopy for pneumocycstis jiroveci was negative.
Figure 1 Chest x-ray showing centrally pronounced bilateral
pulmonary infiltrates with ground-glass opacities.
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The antibiotic treatment was switched to a combination
of clarithromycin 2 × 500 mg/d per os and ceftriaxon 2
g/d intravenously. Under this regime the clinical condi-
tion of the patient improved while the leukocytosis and
c-reactive protein were declining. However, the chest x-
rays showed persistent infiltrates. A second broncho-
scopy was performed and biopsies were taken.
Upon finding of birefringent material the therapy was
supplemented by prednisone 30 mg/d per os. The clini-
cal condition of the patient further improved and he
could be released in good health on day 14. A final
chest x-ray indicated a slight decrease of the pulmonary
infiltration, stepwise reduction of the prednisone and
follow-up chest x-rays were recommended.
Histopathology and energy dispersive x-ray spectroscopy
Histopathological examination of transbronchial biopsies
from the right upper and lower lobe using hematoxylin
and eosin staining revealed chronic as well as active
bronchitis together with active peripheral bronchiolitis
and murally emphasised alveolitis. These findings were
consistent with interstitially accented chronic pneumo-
nia with transition in chronic organising pneumonia
with patchy scarring. Alveolar hemorrhage and dust
laden macrophages were present within the alveolar
spaces and in the interstitium loosely surrounded by
lymphocytes. Anthracotic pigment and fine birefringent
crystal deposits ranging from 1 μmt o2μm in size were
detected by polarized light [Figure 2]. Similar birefrin-
gent particles were found inside alveolar macrophages.
No foreign material was seen in the capillaries of the
alveolar walls. No intravascular granulomas or oblitera-
tive thrombi were present. Methenamine silver and acid
fast staining (Ziehl-Neelsen) did not reveal any myco-
bacteria or fungi.
The birefringent crystals were analysed by energy dis-
persive x-ray spectroscopy (EDX). Silicon was identified
as the major element of the 1 μmt o2μm particles
along with sulfur, carbon and calcium [Figure 3]. Mag-
nesium, sodium and traces of copper were also detected.
Besides the crystaline deposits, tiny (< 1 μm) aluminum
particles were also found.
Discussion
The EDX spectrum showing silicium and magnesium
confirms the presence of materials being used for adul-
teration, in particular talc. Other elements detected by
EDX spectroscopy are in keeping with the suspected
inhalative exposure. Magnes i u mm a yb ea sw e l lr e l a t e d
to magnesium enriched charcoal which enhances
inflammability and thus makes handling more conveni-
ent. The aluminum particles might be attributed to the
stated long term water pipe smoking since common
design of pipes features a layer of aluminum foil cover-
ing incinerated charcoal and providing a surface for a
stack of tobacco. Using enhanced charcoal and alumi-
num foil containing water pipes as described are both
common practice.
A typical EDX-spectrum of talcosis can be found in a
recent case report of occupational talcosis by Neumann
et al. [6]. Silicon, magnesium and oxygen are identified
as leading elements with almost no impurities by other
elements.
Although the clinical and histological findings pre-
sented in this case cannot be regarded as specific, ele-
mental analysis of the birefringent particles in context
with the patient’s history can establishes the diagnosis of
talcosis. In differentiating inhalation talcosis from pul-
monary disease due to intravenous administration the
distribution of inflammatory changes may be helpful with
vascular related lesions tending to develop more com-
monly in talcosis induced by intravenous application.
Figure 2 Lung biopsy showing interstitial accented chronic
inflammation and anthracotic pigment containing fine
birefringent material. A: Overview, HE staining. Scale bar = 200
μm, enlarged area highlighted (black box). B: Enlargement of A
showing the anthracotic pigment and surrounding reactive tissue,
scale bar = 50 μm. C: Same area as B illuminated by polarised light:
Bright deposits of birefringent materials and dimly glowing collagen
fibers.
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intravenous injection the size of the particles has been
postulated to be a discriminator. Particles with a mean
diameter of less than 5 μm are found most commonly in
cases of inhalation talcosis while intravenous exposure
has been reported to cause deposition of larger particles
[7]. The fine deposits found in the biopsies investigated
in this case make intravenous abuse unlikely and point
towards inhalative exposure.
In comparison to interstitial lung disease due to intra-
venous administration of talc during drug abuse talc
inhalation is a rare form of pneumoconiosis most often
caused by occupational exposure. This may be attributed
to its low fibrogenic potential rather than to infrequent
exposure as talcum is widely used in various industrial
processes and products. It has been described to induce
fibrosis to a much lesser extent compared to other
minerals such as quartz and asbestos [8]. Still, talcum
has the potency to initiate fibrosis on its own and extent
of exposure and latency of fibrosis is dose-dependent.
The biopersistency of talcum seems to be high with
deposits identifiable decades after exposure [6]. The
non-occupational inhalative exposure to talc due to
long-term smoking of adulterated cannabis and subse-
quent development of pulmonary disease as described
has been rarely recognized so far. While talcosis is a
recognized complication in abuse of heroin and intrave-
nous consumption of drugs prepared for oral applica-
tion, adulterated cannabis is far less investigated. Only
one case report from France covering the consequences
of adulterated cannabis has been published so far [5].
Delourme et al. describe two patients who consumed
cannabis adulterated either by glass beads or with sand;
interestingly computed tomography of the lungs
revealed ground glass opacities in the later, just like in
this case. The French Department of Health
subsequently issued an advice to consumers regarding
the risks of adulterated cannabis. Cannabis consumption
is a major health issue in the European Union. The life-
time prevalence for occasional cannabis-use among 18-
22 year old adolencents in Germany was estimated to be
40% in 2010. In the same survey, 3% of the 7000 partici-
pants admitted regular cannabis consumption. This cor-
responds to approximately 250 000 individuals if
projected to the German population in that age group
[9]. Lung diseases caused by adulteration substances
may thus be more common than is reflected by current
literature, especially since drug-abuse may not admitted
by a patient.
Conclusions
The exacerbated chronic interstitial lung disease in a
29-year old patient could be attributed to his pro-
longed abuse of adulterated marjuana by histopathol-
ogy and x-ray spectroscopy. Both size and elemental
composition of mineralic deposits found in biopsies
were compatible with inhaled talcum as the leading
contaminant.
Given the high numbers of cannabis users it seems to
be justified to raise attention to this form of interstitial
pulmonary disease. It may be included as a differential
diagnosis in evaluating chronic pulmonary disease in
young adults. If cannabis consumption is suspected, the
patient should be informed about the additional risks of
adulterated cannabis, particularly owing to the fact of
talcum having a long biopersistency.
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